
Dual GIP/GLP-1 Agonist
Dual agonist peptide for advanced metabolic research.
1 Unit
Base Price
$60.00
3-5 Units
Save 10%
$54.00
$60.00
6-9 Units
Save 15%
$51.00
$60.00
10+ Units
β Best ValueSave 20%
$48.00
$60.00
π‘ Volume discounts available for bulk orders
RESEARCH USE ONLY: FOR RESEARCH USE ONLY: This product is intended for laboratory and research purposes only. Not for human or animal consumption. By purchasing, you confirm this product will be used exclusively for legitimate research.
Dual agonist peptide for advanced metabolic research.
Tirzepatide is a novel dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist. It represents a new class of incretin-based therapeutics with enhanced efficacy compared to single-receptor agonists.
Key Research Areas:
β’ Superior glycemic control
β’ Significant weight reduction
β’ Improved insulin sensitivity
β’ Cardiovascular benefits
β’ Metabolic optimization
Clinical trials have shown tirzepatide to produce unprecedented weight loss results compared to other incretin-based therapies.
RESEARCH USE ONLY: All products sold on this website are intended for laboratory and research purposes only. These products are NOT intended for human or animal consumption.